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Abstract
Background: Growth charts based on data collected in different populations and time periods are key tools to assess
children’s linear growth. We analyzed the impact of geographic factors and the secular trend on height-for-age charts
currently used in European populations, developed up-to-date European growth charts, and studied the effect of using
different charts in a sample of growth retarded children.
Methods and Findings: In an international survey we obtained 18 unique national height-for-age charts from 28 European
countries and compared them with charts from the World Health Organization (WHO), Euro-Growth reference, and Centers
of Disease Control and Prevention (CDC). As an example, we obtained height data from 3,534 children with end-stage renal
disease (ESRD) from 13 countries via the ESPN/ERA-EDTA registry, a patient group generally suffering from growth
retardation. National growth charts showed a clear secular trend in height (mean height increased on average 0.6 cm/
decade) and a North-South height gradient in Europe. For countries without a recent (.1990) national growth chart novel
European growth charts were constructed from Northern and Southern European reference populations, reflecting
geographic height differences in mean final height of 3.9 cm in boys and 3.8 cm in girls. Mean height SDS of 2- to 17-year-
old ESRD patients calculated from recent national or derived European growth charts (21.91, 95% CI: 21.97 to 21.85) was
significantly lower than when using CDC or WHO growth charts (21.55, 95% CI: 21.61 to 21.49) (P,0.0001).
Conclusion: Differences between height-for-age charts may reflect true population differences, but are also strongly
affected by the secular trend in height. The choice of reference charts substantially affects the clinical decision whether a
child is considered short-for-age. Therefore, we advocate using recent national or European height-for-age charts derived
from recent national data when monitoring growth of healthy and diseased European children.
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Introduction
Age- and sex-specific growth charts are essential clinical tools to
monitor the adequacy of children’s longitudinal growth.[1–3]
Impaired growth is a major global public health issue [4], and its
correct diagnosis is crucial to prompt timely intervention.
Although many different national and international growth charts
for height exist [1], national growth charts are unavailable in
numerous countries. Therefore, the 1977 National Center for
Health Statistics/World Health Organization (NCHS/WHO)
references have been recommended for worldwide use. [3]
Recently, the Centers of Disease Control and Prevention (CDC)
[5] and the WHO [6] released revised versions of the NCHS/
WHO growth charts. However, as both datasets are mainly based
on data collected more than forty years ago, they may be outdated
because of the secular trend in height. Moreover, the NCHS/
WHO charts describe the growth of US children, and thus do not
represent an international sample. Therefore, in 2006 the WHO
released international growth standards for children aged 0–5
years based on growth data of children from six countries around
the globe. The growth data were collected from children living
under optimal conditions.[7–9] These growth standards were
intended to replace national growth charts in young children.
Furthermore, in 2000 the Euro-Growth Study Group released
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reference charts for infants younger than 3 years based on a
sample from twelve European countries. [10,11] Although the
WHO growth standards were designed to be applicable to all
children around the globe, in some Northern European countries
heights of 0–5 year olds appeared to be larger than the supposedly
‘ideal heights’ according to WHO growth standards [12–14],
questioning the universal applicability of the WHO growth
standards. In daily practice, most countries preferentially apply
their national height-for-age charts [1] whenever available, even
when these are based on ‘outdated’ data. While this practice may
cause problems because of the secular trend in height, the use of
the CDC data may not provide a sufficient solution. [15].
The impact of the choice of growth charts is even more
important to consider when analyzing longitudinal growth of
children from different countries, a task of increasing importance
with the emergence of multinational pediatric registries and
clinical trials. We recently encountered this problem when
studying longitudinal growth in European children with end-stage
renal disease within the framework of the ESPN/ERA-EDTA
Registry. Highly diverse populations, major regional variation in
the tempo of growth, and the availability of several national
growth charts of variable actuality in Europe illustrate the
challenge of applying adequate reference methods to a heteroge-
neous population.[7,12,13,16–18] In this study, we addressed this
issue in a three-stage approach: (1) assess the appropriateness of
different growth charts for height in current use in European
countries; (2) develop an optimized set of valid height-for-age
charts applicable throughout Europe; and (3) illustrate the impact
Table 1. Characteristics of different growth charts.
Country or growth
chart
Years of
Survey
Ages
(years)
Number of
children
Sample
representative
for entire country Exclusion criteria
Modeling technique
used
Belgium [19] 2002–2004 0–21 15,989 No1 Non Belgian parents, chronic illness,
born before 37 weeks
LMS
Czech Republic [20] 2001 0–19 59,000 Yes
Denmark [21] 1974 0–18 13,210 Yes Non Danish parents
Estonia [22] 1996–1997 2–20 20,367 Yes cubic splines
Finland [23,24] 1959–1983 0–19 2,897 No1 Born before 36 weeks, birth weight
,2500 g, chronic illness
Spline function
France [25] 1953–1975 0–20 497 Weighted LS
Greece [26] 2000–2001 0–18 9,797 No1 LMS
Germany [13] 2003–2006 0–18 17,079 Yes Illness and medications that could affect
growth
LMS
Hungary [27] 1979 3–18 5,685
Italy [28] 1996–2004 2–20 69,917 Yes Extended mechanistic
growth function (EMGF)2
Lithuania [29] 1996–2003 0–18 9,000 Yes
Netherlands [30] 1996–1997 0–25 14,500 Yes Illness and medications that could affect
growth
LMS
Norway [18] 2003–2006 0–19 8,299 No One/both parents outside Northern Europe,
chronic illness, prematurity
LMS
Russia [31]3 1980’s 0–17
Spain [32] 2000–2004 0–18 32,064 Yes Non Spanish parents, chronic illness,
medication use
LMS
Sweden [33] 1992 0–18 3,650 Yes Polynomial function
Switzerland [34] 1954–1976 0–20 274 Yes Non Swiss parents, birth weight ,2500 g,
illness
Spline function
United Kingdom
[35,65]4
1972–1993 0–23 25,385 Yes Non-Caucasian children LMS
CDC [37] 1963–1994 0–19 950,928 Yes Birth weight ,1500 g LMS
WHO growth standards
[9]
1996–2003 0–5 8,440 Yes Health, environmental, or economic
constraints to growth (morbidities, multiple
birth etc.)
BCPE with cubic splines
WHO growth charts [6] 1963–1974 5–19 22,917 Yes Birth weight ,1500 g
Euro-Growth reference
[10]
1990–1996 0–3 2,245 Yes Illness, birth before 37 weeks, birth weight
,2500 g
1Although the sample was not population based, the authors stated that height of sampled children will likely not be different from children living in other regions in
the country;
2Method similar to LMS method;
3Russian charts are published in a key pediatric book, and are commonly applied by pediatricians throughout Russia;
4The UK-WHO growth charts are applied in clinical practice in the United Kingdom and constitute growth data from WHO growth standards with birth data from the
British 1990 charts. As the WHO growth standards are already included in the analyses, the new WHO-UK growth charts were not considered.
doi:10.1371/journal.pone.0042506.t001
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Figure 1. Mean ±2 SE of height for different growth charts by sex and age.
doi:10.1371/journal.pone.0042506.g001
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of the use of different height-for-age charts on an international
population with growth retardation, i.e. children with end-stage
renal disease.
Methods
Growth Charts
Currently available height-for-age charts. In November
2010, we conducted a survey among pediatric centers in 32
European countries in order to obtain information on height-for-
age charts used in clinical practice. A response was obtained from
28 countries (88%). Eighteen countries used a unique height-for-
age chart based on data from their own country. Table 1 provides
an overview of the different charts included in this study. National
growth charts for height were available for Belgium [19], Czech
Republic [20], Denmark [21], Estonia [22], Finland [23,24],
France [25], Greece [26], Germany [13], Hungary [27], Italy
[28], Lithuania [29], the Netherlands [30], Norway [18], Russia
[31], Spain [32], Sweden [33], Switzerland [34], and the United
Kingdom. [35,36] Furthermore, we included the international
reference charts for height of Euro-Growth [10], CDC [37] and
WHO. [6,9].
The Euro-Growth reference included longitudinal growth data
up to 36 months of age from a sample of twelve European
countries. The WHO growth standards consist of longitudinal
growth measurements from birth to 24 months, followed by cross-
sectional data till the age of 5 years based on data from six
countries around the globe.
Construction of growth charts for Northern and Southern
Europe. To replace older national height-for-age charts and to
provide reference tables for those countries in which national
growth charts are unavailable, we developed two sets of European
reference charts for height accounting for the secular trend as well
as for the North-South gradient in height. [16] Based on serial t-
testing of different cut-offs to identify the partition yielding the
most significant difference in mean heights, we considered charts
for which the midyear of height data collection was 1990 as up-to-
date. For each recent national chart we weighted the mean height
and the standard deviation for each six month age interval for the
country’s total population size in 2010 and combined these values
to create a weighted average for Northern and Southern Europe.
Pediatric End-Stage Renal Disease Patients: an Example
Subjects. Data on pediatric end-stage renal disease patients
were collected within the framework of the ESPN/ERA-EDTA
Registry and included date of birth, sex, treatment modality (i.e.
dialysis or transplantation) at start of renal replacement therapy,
and changes in treatment modality. For the present study, we
included patients younger than 18 years, who started renal
replacement therapy during the period 1995–2010. The most
recent height measurement available in the registry was included
for: Belgium, Czech Republic, Finland, France, Italy (2–17 years
old), Lithuania, Norway, Romania, Russia, Slovakia, Spain,
Switzerland, and the United Kingdom.
Data analysis. The most recent height measurement of each
patient was converted to length/height-for-age standard deviation
scores (SDS) using recent national growth charts whenever
available. For countries lacking recent national charts SD scores
were calculated using the European height-for-age charts
constructed in this study. The mean SD scores for patients from
separate European countries as well as for all countries combined
were then compared with the length SDS calculated from WHO
growth standards and Euro-Growth reference for 0–1 year olds
and with height SDS according to CDC and WHO growth charts
for 2–17 year old children. CDC growth charts in the 0–1 year old
group were not included in the comparison since for this age group
the use of the WHO growth standards is recommended. [38].
To determine whether children were short-for-age we used a
length/height SDS cut-off value of ,22.
All statistical analyses were carried out using SAS version 9.2
(SAS Institute Inc., Cary, NC, USA).
Results
Differences between Growth Charts
The height distribution differed substantially between growth
charts. Figure 1 shows the absolute mean heights 62 SE
according to different reference charts (i.e. charts based on recent
data as well as those based on data collected before 1990) by sex
and for four selected ages.
Most national height-for-age charts showed higher mean
heights than those according to the Euro-Growth reference and
the WHO growth standards for one-year-old children, or
according to CDC and WHO growth charts for 5, 10 and 18
year old children. Mean height differences among 1 year old
children were only marginal and not significant.
We tested whether these differences in mean heights were
related to the secular trend in height by plotting the midyear of the
survey in which growth chart height data were collected against
the mean height for the four selected age groups (Figure 2). Recent
surveys showed consistently higher mean heights, reflecting a
positive secular trend in height. In 18 year old girls the secular
trend was, however, smaller compared to younger ages. Differ-
ences in mean heights were highly significant when collection
midyear of 1990 was used as a cut-off to determine which charts
were up-to-date. As a result, we considered growth charts based on
data collected before 1990 to be outdated.
Besides the secular trend in height, growth charts also varied
due to differences in study design (in-and exclusion criteria) and
due to modeling techniques used to construct the charts (Table 1).
Between the recent growth charts for height (.1990) there were,
however, no apparent differences between these factors.
Growth Charts for Height for Northern and Southern
Europe
The height-for-age chart for Northern Europe was based on the
charts from Belgium, [19] Czech Republic [20], Estonia [22],
Germany [13], Lithuania [29], the Netherlands [30], Norway
[18], and Sweden [33], whereas the height-for-age chart for
Southern Europe was compiled from the charts of Greece [26],
Italy [28], and Spain. [32] Recent height-for-age charts for
Southern European countries generally showed lower mean
heights than recent charts for Northern European countries,
suggesting a North-South gradient in height (Figure 2), especially
in children older than 5 years of age where a significant gradient
was observed. For example, 18- year-old boys in Southern Europe
were on average 3.9 cm shorter than their peers living in Northern
European countries (P,0.05). To allow for this geographical
height gradient and to correct for the secular trend we developed
two separate height-for-age charts for Northern and Southern
European children (Figures 3 and 4). Standard deviation scores
(SDS) by sex at 6-month age intervals are given in Appendix S1.
Differences in Height-for-age Charts in Pediatric End-
stage Renal Disease Patients
To illustrate the impact of the use of different growth charts on
linear growth data from a population frequently suffering from
growth retardation, we applied the charts to a population of
Height-For-Age Charts for European Children
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Figure 2. Mean heights by midyear of data collection for different growth charts.Mean heights are shown for 1, 5, 10, and 18 year old boys
and girls (m=national growth charts before 1990;&=national growth charts of Southern European countries after 1990;N=national growth charts
for Northern European countries after 1990; .=CDC growth charts for 5, 10, and 18 year olds; m=WHO growth charts for 5, 10, and 18
Height-For-Age Charts for European Children
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children with end-stage renal disease. For countries with national
height-for-age charts based on data collected before 1990, mean
height SDS is shown according to these national growth charts, as
well as to our newly constructed European growth charts to
illustrate the differences. The European growth charts were used
in children from those countries in which recent national growth
charts for height are unavailable, i.e. the Northern European
charts in children from Finland, Russia, Slovakia, and the United
Kingdom, and the Southern European charts in children from
France, Romania, and Switzerland.
Length/height SDS calculated using different growth charts for
0–1 year old and 2–17 year old end-stage renal disease patients
are shown in Table 2 and 3, respectively. For 0–1 year old end-
stage renal disease patients we found small, non-significant,
differences when applying different growth charts. The mean
length SDS according to the Euro-Growth reference
(22.2260.19) and the WHO growth standards (22.2460.19)
were slightly lower than for national growth charts: 22.0460.19
for national charts including growth charts from before the 1990s
and 22.0560.17 for recent national/European growth charts.
The proportion of children rated short-for-age was similar
according to Euro-Growth reference (50%), WHO growth
standards (47%), national growth charts (including those from
before 1990) (49%) and recent national/European growth charts
(47%) (Fig. 5).
For 2–17 year old end-stage renal disease patients mean height
SDS based on recent national/European growth charts were lower
compared to the national growth charts including those based on
data collected before 1990 (Table 3). Overall, the mean height
SDS according to recent national/European growth charts
(21.9160.03) was significantly lower than when calculated using
the CDC and WHO growth charts (21.5560.03), while the
height SDS calculated according to national growth charts
including growth charts from before 1990 yielded intermediate
year olds; N= Euro-Growth for one year olds; and¤=WHO growth charts for one-year olds; horizontal lines represent the mean height for Northern
and Southern Europe in the growth charts based on data after 1990).
doi:10.1371/journal.pone.0042506.g002
Figure 3. New growth charts proposed for Northern European countries without recent national growth charts. Outer lines indicate
22.5 SDS and +2.5 SDS.
doi:10.1371/journal.pone.0042506.g003
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values (21.7560.03) (Table 3). Hence, children appeared shorter
according to recent national/European growth charts (Fig. 5) and
more children were classified as short-for-age according to these
recent national/European growth charts (44%) as compared to
CDC (34%) or WHO (33%) and national growth charts including
charts from before 1990 (40%).
Discussion
We found that the mean heights of the general pediatric
population, as reflected in growth charts, vary substantially. To
determine whether the longitudinal growth pattern of a child is
normal, height should be compared to an appropriate reference
population. [16,39,40] Defining the appropriate reference popu-
lation is, however, a matter of debate. Some studies suggested the
use of one single height-for-age chart worldwide [7,16], whereas
other studies found significant population differences in height,
therefore, advocating the use of national height-for-age charts.
[12,13,18].
The variation in linear growth charts appeared to be related
both to the era of data collection and to true population
differences. Growth charts for height constructed from data
collected before 1990, including the CDC and WHO growth
charts, yielded generally lower mean heights than those developed
more recently. Since 1850 there has been a positive secular trend
in height among European populations. [15,41,42] Like in the
United States [5], in many Northern European countries as well as
in Italy this secular trend slowed down or even reached a plateau
since the 1980s/1990s [15,43–46], whereas in other countries, like
Belgium, Spain, and Portugal, average heights might still increase.
[45].
We found considerable differences in mean heights among
European populations, with children from Northern Europe
generally being taller than those from Southern Europe [43,45–
47], suggesting a North-South height gradient in European
children older than 5 years of age. For example, in the European
growth charts developed in this study mean height at age 18 years
is 166.7 cm for Northern European girls while it is 162.8 cm for
Southern European girls. These findings are in keeping with
previous studies reporting a clear difference in height between
Scandinavian countries, the Netherlands and Germany as
compared to countries in the Mediterranean region (e.g. France,
Italy, Portugal, and Spain). [43,45,47] These marked population
differences could be related to environmental, socio-economical,
Figure 4. New growth charts proposed for Southern European countries without recent national growth charts. Outer lines indicate
22.5 SDS and +2.5 SDS.
doi:10.1371/journal.pone.0042506.g004
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and/or genetic factors. [16,47] Population differences could also
be related to differences in the extent of the secular trend, which
started earlier in Northern Europe than in Southern Europe,
leading to taller statures in Northern Europe. [41] Furthermore, as
the onset of puberty occurs later in Northern Europe, possibly due
to a lower obesity prevalence [48] or genetic factors [49], final
adult height could be higher in Northern Europe than in Southern
Europe. [49] Some of the length variation among infants might
have been caused by differences in the ages at which measure-
ments switched from recumbent length to standing height, as well
as by the difficulty to measure recumbent length. [50] It has been
suggested that weight-for-age might provide a more reliable tool
for infant growth monitoring. [51].
The secular trend in height mandates regular updating of
growth references in order to detect children who have a short
stature relative to their peers. Recent single-country height-for-age
charts based on sufficiently large representative samples of
children can be assumed to provide optimal reference information.
However, such studies are infrequently performed due to high
workload, high costs and limited scientific value. [52] In our study,
Table 2. Mean length SDS for 0–1 year old end-stage renal disease patients.
Country Mean length SDS (SE)
N National1 Recent National/European WHO Euro-Growth2
Belgium 2 22.62 (1.64) 22.62 (1.64) 23.07 (1.19) 22.62 (1.59)
Czech Republic 3 21.80 (0.70) 21.80 (0.70) 21.91 (0.91) 21.99 (0.85)
Finland 7 21.39 (0.46) 21.33 (0.47) 21.24 (0.50) 21.26 (0.49)
France 20 21.91 (0.42) 22.12 (0.36) 22.56 (0.43) 22.46 (0.41)
Lithuania 2 21.00 (0.26) 21.00 (0.26) 21.07 (0.36) 21.11 (0.36)
Norway 1 20.90 20.90 20.83 21.03
Romania 1 1.97 1.16 1.25 1.08
Russia 4 22.50 (1.15) 23.23 (1.13) 23.22 (1.26) 23.27 (1.22)
Spain 22 21.72 (0.33) 21.72 (0.33) 21.99 (0.35) 21.99 (0.38)
Switzerland 3 20.89 (0.86) 20.75 (0.85) 21.09 (0.61) 20.86 (0.76)
United Kingdom 21 23.13 (0.37) 22.83 (0.28) 22.84 (0.30) 22.87 (0.30)
All countries3 86 22.04 (0.19) 22.05 (0.17) 22.24 (0.19) 22.22 (0.19)
1National growth charts refer to both growth charts based on data collected before 1990 as well as to recent national growth charts;
2As the CDC recommends the use of the WHO growth standards for children under the age of 2 years, mean length SDS values based on the CDC for children younger
than 2 years are not reported;
3These values represent the average length SDS of children with ESRD from all European countries together.
doi:10.1371/journal.pone.0042506.t002
Table 3. Mean height SDS for 2–17 year old end-stage renal disease patients.
Country Mean height SDS (SE)
N National1 Recent National/European WHO CDC2
Belgium 8 20.16 (0.47) 20.16 (0.47) 0.01 (0.49) 0.04 (0.47)
Czech Republic 45 21.81 (0.17) 21.81 (0.17) 21.23 (0.16) 21.21 (0.16)
Finland 124 21.46 (0.11) 21.79 (0.11) 21.25 (0.11) 21.23 (0.11)
France 289 21.47 (0.11) 21.83 (0.11) 21.59 (0.10) 21.59 (0.10)
Italy 541 22.13 (0.07) 22.13 (0.07) 21.83 (0.06) 21.80 (0.06)
Lithuania 28 21.52 (0.40) 21.52 (0.40) 21.12 (0.40) 21.10 (0.38)
Norway 54 21.82 (0.19) 21.82 (0.19) 21.30 (0.17) 21.28 (0.17)
Romania 73 23.39 (0.21) 23.68 (0.20) 23.22 (0.18) 23.22 (0.17)
Russia 234 22.06 (0.13) 22.74 (0.12) 22.23 (0.12) 22.21 (0.12)
Slovakia 6 21.57 (0.47) 21.54 (0.45) 21.13 (0.46) 21.07 (0.45)
Spain 729 21.43 (0.05) 21.43 (0.05) 21.35 (0.05) 21.36 (0.05)
Switzerland 170 21.25 (0.11) 21.26 (0.12) 21.06 (0.10) 21.05 (0.10)
United Kingdom 1101 21.79 (0.03) 21.99 (0.02) 21.43 (0.02) 21.44 (0.02)
All countries3 3402 21.75 (0.03) 21.91 (0.03) 21.55 (0.03) 21.55 (0.03)
1National growth charts refer to both growth charts based on data collected before 1990 as well as to recent national growth charts;
2Height-for-age reference values according to the Euro-Growth reference are not available for children over the age of 3 years;
3These values represent the average height SDS of children with ESRD from all European countries together.
doi:10.1371/journal.pone.0042506.t003
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national growth charts for height were lacking in 10 out of 28
countries (36%), outdated charts were used in 5 others (18%), and
national charts from other countries, which were not necessarily
the most appropriate ones, were used in 3 countries (11%). The
selection of children included in national growth charts or the use
of modeling techniques did not differ systematically between
recent national growth studies from Northern and Southern
Europe. Therefore, the reference charts developed in this study for
Northern and Southern European populations based on all recent
national height-for-age charts available to us, may take the role to
monitor linear growth of children in countries where recent
national growth charts are lacking. It should be emphasized
though that this ‘geographic interpolation’ approach cannot
replace and should not preclude regular monitoring of the growth
and nutritional status of (healthy) children in all European
countries.
The issue raised here is not only of anthropological interest, but
has also important clinical implications. Since clinical decision-
making such as the indication for growth hormone or other growth
promoting therapies [53,54] are based on the comparison of an
individual child’s height to the height distribution of the peer
population, differences between height-for-age charts may have
considerable implications for individual patients. Also, for public
health purposes, as stunting is one of the main contributors to the
global burden of disease [4], it is of major importance to prompt
intervention in the right children. When a reference population is
taller, more children will meet the criterion of having a height SDS
below 22. So, based on older national, CDC, or WHO reference
charts (5–19 years) fewer children will be considered eligible for
growth promoting therapy compared to recent national growth
charts. This was shown in Australia, where children having a
height SDS , 22.3 (or ,1st percentile) based on CDC growth
charts were considered eligible for subsidized rhGH treatment.
Theoretically, 1% of the Australian children should meet this
criterion. However, only 0.5% of the Australian children had a
height SDS below the 1st percentile of the CDC growth charts.
[53] We found that 34% of the 2–17 year old children with end-
stage renal disease would be eligible for growth hormone therapy
by using WHO or CDC growth charts, whereas 44% would meet
the criterion when using recent national or the European growth
charts derived here. Regulatory authorities both at the national
and at the European level have precisely defined the indications
for growth-modulating therapies according to height and growth
velocity criteria. [55,56] It is of major concern that in many
instances these well-defined criteria are applied using inappropri-
ate reference charts. The variable actuality and representativeness
of height-for-age charts used in different European countries
violates the objective of equal access to health care for all
European children [57], and defines the need for a Europe-wide,
periodically updated study of growth, development and nutrition
in healthy children.
Finally, in international growth or registry studies, when
comparing linear growth data from different ethnic or geographic
sources, international charts do not represent local growth
appropriately due to population differences in height. Neverthe-
less, in these studies, the newly constructed height-for-age charts
Figure 5. Height-SDS and prevalence of short stature for different growth charts in end-stage renal disease patients. Mean height-
SDS and prevalence of short stature according to different growths are shown separately for 0–1 year old and 2–17 year old patients. The National
growth charts include both recent national growth charts as the growth charts based on data collected before 1990.
doi:10.1371/journal.pone.0042506.g005
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for Northern and Southern European populations might serve as
appropriate reference charts because these better approach
geographical height differences compared to one single interna-
tional growth chart (e.g. CDC or WHO growth chart).
A possible limitation of our study is that the overview of
national growth charts in this study may be incomplete, as we
only included those charts which are applied in pediatric
nephrology practice, a discipline in which growth retardation is
relatively common. The choice of national growth charts for
studying height could be slightly different for other medical
disciplines. Moreover, the European height-for-age charts were
not smoothed using the standard LMS method [58] as we were
not able to retrieve the original data from the included growth
studies. However, the original growth data were smoothed prior
to construction of the European growth charts which largely
removed random variation in the original data, resulting in
relatively smooth charts.
As the original height-for-age charts on which our European
charts are based did not provide information on gestational age
and neither on linear growth of children from non-Western
immigrants, our growth charts might not be applicable to small for
gestational age babies or children from ethnic minorities living in
Europe. However, several reference charts correcting for gesta-
tional age [59,60], as well as reference charts specifically designed
for growth monitoring of immigrant children [61–64], are
available in literature. Furthermore, our charts also will require
periodical updating in order to keep pace with height and ethnic
changes in the reference population.
Conclusion
We found considerable differences in mean heights among
different growth charts with height SDS in children differing
depending on the reference chart used. The differences are likely
due to the secular trend in height as well as to geographical
differences in height. Therefore, we developed new height-for-age
charts for Northern and Southern European countries. When
monitoring longitudinal growth of European children, we propose
to use recent national growth charts. However, if these are lacking
we suggest that height-for-age charts for Northern and Southern
Europe based on recent national charts, like ours, are preferable to
other national or international height-for-age charts.
Supporting Information
Appendix S1 A) Growth charts constructed for Northern
European boys; B) Growth charts constructed for Northern
European girls; C) Growth charts constructed for Southern
European boys; D) Growth Charts constructed for Southern
European girls.
(DOC)
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